Meta, Amazon and Microsoft lead an earnings wave, along with a Fed meeting and Trump tariff deadline. Tesla robotaxi may ...

Recognify Life Sciences, a company Atai Life Sciences is a strategic investor in, said its trial for a cognitive decline treatment missed its primary endpoint. Atai shares fell 13% to $3.08 in ...

Italian oil major Eni raised some 2025 growth projections and said it would buy back up to roughly $1.76 billion of shares over the year despite commodity and currency headwinds. Write to Rob Curran ...

Dow's 17% plunge and 50% dividend cut reflect deep cyclical challenges, weak margins, and heavy debt. Click here to find out ...

ETFs now have a 35% market share of combined US assets in ETFs and open-end mutual funds as of June from less than 1% through ...

JPMorgan Chase continues to outperform in 2025, navigating inflation and policy risks while offering investors a compelling ...

Phillips 66 PSX +0.99% Get Free Report reported better-than-expected second-quarter financial results. Phillips 66 posted ...

Investors are benefiting as the FTSE 100 hits record highs - here are the best performing shares and funds so far this year ...

Stock futures are slightly higher Friday morning at the end of a busy week of earnings reports and trade-related news.

Yesterday we gave the markets a Neutral or Mixed bias and the markets didn't disappoint. The Dow dropped 316 points, but the ...

Bristol Myers Squibb's chief medical officer, Samit Hirawat, is leaving the drugmaker to pursue new professional opportunities.